1 results match your criteria: "University of Pretoria and Lancet Laboratories[Affiliation]"
The use of molecular markers for cervical screening of women living with HIV in South Africa.
AIDS
November 2019
aDepartment of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands bDepartment of Obstetrics and Gynaecology, Steve Biko Academic Hospital, University of Pretoria cDepartment of Medical Virology, University of Pretoria and Lancet Laboratories, Pretoria, South Africa.
Objective: To determine the performance of molecular screening strategies for detection of cervical intraepithelial neoplasia grade 3 or worse (CIN3+) in comparison with cytology screening in women living with HIV.
Design: Post-hoc analysis using data from a South African study cohort.
Methods: Cytology and human papillomavirus (HPV)-based strategies were evaluated, including single test and FAM19A4/miR124-2 methylation triage strategies.